Based on the domestic market, Longtime Pharmaceutical is actively expanding overseas markets.

The drug has been clinically tested in more than a dozen countries including Turkey (EU standard), India and Malaysia. Growth factor raw materials and cosmetic products have achieved small-scale export sales. The company is currently negotiating with customers in South Korea, Hong Kong and Taiwan, with an aim to achieve deeper cooperation.